SlideShare una empresa de Scribd logo
1 de 27
Descargar para leer sin conexión
OPENING PRAYER
DEAR HEAVENLY FATHER,
WE THANK YOU FOR GATHERING ALL OF US TODAY IN THIS IMPORTANT EVENT
MAY YOU BESTOW YOUR GUIDANCE AND BLESSINGS ON THIS EVENT,
SO THAT WE CAN ENJOY AND APPRECIATE ITS SIGNIFICANCE IN OUR LIVES
BLESS EVERYONE PRESENT HERE TODAY,
THAT EACH OF US MAY BE ABLE TO SHARE WHAT HE OR SHE HAVE,
FOR YOUR GLORY AND HONOR
GRANT GOOD HEALTH AND SAFETY TO OUR LOVED ONES LEFT AT HOME, AND PEACE AND GOOD
WILL TO ALL MEN.
MAY THE VARIOUS ACTIVITIES RELATED TO THIS EVENT BE A SUCCESS,
THROUGH YOUR INTERVENTION
WE ASK ALL OF THESE IN YOUR NAME,
AMEN.
HUMAN MONKEYPOX
By:
GERESA G. SALTA-SAMONTE,M.D.
Occupational/ Family Medicine
Infectious Diseases & Tropical Medicine
Few Questions Before We Start
 1. Are monkeys the natural reservoir of monkeypox
virus?
 2. How can we differentiate monkeypox from
chickenpox?
 3. What is the duration of quarantine if you have
been exposed to someone with monkeypox?
Background:
 1st identified in monkeys in 1958
 1st human case reported in 1970
 Endemic in areas of Africa
 Typically, only see sporadic cases outside of Africa in people who have traveled to
certain regions or have been in close contact with those travelers
 From the 1970s up until 2003, sporadic cases were identified in central and western
Africa
 Before 1980, case-fatality rate was 17% and secondary transmission was the cause in
9% of cases
 From 1981 to 1986, the case-fatality rate was 10% and secondary transmission was
the cause in 28%
 From 1996 to 1997, the largest outbreak of human monkeypox occurred, which had a
case-fatality rate of 1.5% and secondary transmission was the cause in 78%
 The 2003 outbreak, was the first documented cases in the western hemisphere with a
case-fatality rate of 0% and secondary transmission was the cause in 0%
 Cases of Monkeypox in 2022 from May 6th – 20th [2]:
 UK: 20 (Confirmed)
 Spain: 23 (Unconfirmed)
 Portugal 5 (Confirmed) + 15 (Unconfirmed)
 US 1 (Confirmed)
What is Monkeypox?
 Monkeypox is a disease caused by the monkeypox
virus. It is a viral zoonotic disease, meaning that it
can spread from animals to humans. It can also
spread between people.
 The disease is called monkeypox because it was first
identified in colonies of monkeys kept for research in
1958. It was only later detected in humans in 1970.
Mode of transmissions:
Primary infection (animal to human)
a) contact with infected animals
b) contact with infected animal products
 Secondary infection (human to human)
a) contact with infected people
b) mother to fetus
Is Monkeypox a sexually
transmitted disease?
 Monkeypox can spread from one person to another
through close physical contact, including sexual contact.
It is currently not known whether monkeypox can be
spread through sexual transmission routes (e.g., through
semen or vaginal fluids), but direct skin-to-skin contact
with lesions during sexual activities can spread the virus.
 Monkeypox rashes are sometimes found on genitals and
in the mouth, which is likely to contribute to transmission
during sexual contact. Mouth-to-skin contact could thus
cause transmission where skin or mouth lesions are
present.
Signs & symptoms
Disease Progression:
 Incubation period (5- 21 days)= the virus enters the
body & replicates. No symptoms. Virus is present in
the blood at the end of this stage
 Febrile stage ( 1-4 days)= fever is present plus other
symptoms like headache, chills, sore throat, malaise,
fatigue, swollen lymph nodes (lymphadenopathy).
Virus is present in the blood & small lesions in the
mouth may appear towards the end.
 Rash stage2 (4 weeks)
 Recovery (days to weeks)
Rash Stage
 Rash begins as maculopapular lesions of 2 to 5mm
in diameter
 Typically, centrifugal pattern (from the torso
outwards)
 Skin lesions typically progress from macular, papular,
to vesicular, to pustular, and crust phases over a 14
to 21-day period
 In patients with smallpox vaccination the rash will be
milder and only ≈50% will have lymphadenopathy
Rash stage
 Rash stage
- virus maybe in the blood in the early stage
- virus is present in the skin lesions
- antibodies are produced & detectable
 Recovery stage
- patient recovers
- antibodies are present in the blood
- scars may remain
- no more symptoms
Factors affecting the course of
the disease:
1. Asymptomatic infection may occur
2. Risk factors for severe illness:
a) children
b) immunocompromised
c) invasive route
3. Prior smallpox vaccination
Complications:
 Bacterial superinfection of skin
 Skin scarring
 Corneal scarring/vision loss
 Pneumonia
 Dehydration (secondary to painful oral lesions and
insensible fluid loss)
 Encephalitis
 Death (Very rare)
How can we protect ourselves
against monkeypox?
 by limiting contact with people who have suspected
or confirmed monkeypox.
 If you do need to have physical contact with
someone who has monkeypox because you are a
health worker or live together, encourage the
infected person to self-isolate and cover any skin
lesion if they can (e.g., by wearing clothing over the
rash).
 wear a medical mask, especially if they are
coughing or have lesions in their mouth. You should
wear one also.
 Avoid skin-to-skin contact whenever possible and
use disposable gloves if you have any direct contact
with lesions.
 Wear a mask when handling any clothes or bedding
if the person cannot do it themselves.
 Regularly clean your hands with soap and water or
an alcohol-based hand rub
 Wash the person’s clothes, towels and bedsheets
and eating utensils with warm water and detergent.
What to do when you think you
have monkeypox?
 Self-isolate
 Avoid close contact
 Clean hands regularly
 Contact your physicians
Treatment:
 There is no proven treatment for monkeypox
 For contacts of a case, recommend twice daily fever/symptom monitoring for 21 days
+ Isolation recommended
 Currently, CDC recommending airborne and contact precautions (i.e. negative
pressure room, N95, gloves, and eye shield)
 Pre-exposure smallpox vaccination has been shown to confer 85% protection against
monkeypox
 Role of post-exposure smallpox vaccination is less clear
 According to the CDC, vaccination within 4 days of exposure may prevent disease
onset and vaccination within 14 days may reduce disease severity
Opening Prayer for an Important Event
Opening Prayer for an Important Event

Más contenido relacionado

Similar a Opening Prayer for an Important Event

Similar a Opening Prayer for an Important Event (20)

Health-8-communicable diseases lesson.pptx
Health-8-communicable diseases lesson.pptxHealth-8-communicable diseases lesson.pptx
Health-8-communicable diseases lesson.pptx
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
Smallpox
 Smallpox  Smallpox
Smallpox
 
Yaws
YawsYaws
Yaws
 
MonkeyPox Virus
MonkeyPox Virus MonkeyPox Virus
MonkeyPox Virus
 
Swine Flu (H1 N1) Yusuf Yasin Kumbul
Swine Flu (H1 N1)   Yusuf Yasin KumbulSwine Flu (H1 N1)   Yusuf Yasin Kumbul
Swine Flu (H1 N1) Yusuf Yasin Kumbul
 
MEASLES - THEORY.ppt
MEASLES - THEORY.pptMEASLES - THEORY.ppt
MEASLES - THEORY.ppt
 
Monkeypox RA and Mx 27 Mei 2022.pptx
Monkeypox RA and Mx 27 Mei 2022.pptxMonkeypox RA and Mx 27 Mei 2022.pptx
Monkeypox RA and Mx 27 Mei 2022.pptx
 
monkeypox- amended 2.pptx
monkeypox- amended 2.pptxmonkeypox- amended 2.pptx
monkeypox- amended 2.pptx
 
Chickenpox and smallpox
Chickenpox  and  smallpoxChickenpox  and  smallpox
Chickenpox and smallpox
 
Corona ebook
Corona ebookCorona ebook
Corona ebook
 
Tuberculosis.man
Tuberculosis.manTuberculosis.man
Tuberculosis.man
 
Ready Army: Swine influenza
Ready Army: Swine influenza Ready Army: Swine influenza
Ready Army: Swine influenza
 
SUMMARIZE EACH SECTION OF THE.pdf
SUMMARIZE EACH SECTION OF THE.pdfSUMMARIZE EACH SECTION OF THE.pdf
SUMMARIZE EACH SECTION OF THE.pdf
 
Staph research paper
Staph research paperStaph research paper
Staph research paper
 
Monkeypox_An overview.pptx
Monkeypox_An overview.pptxMonkeypox_An overview.pptx
Monkeypox_An overview.pptx
 
Corona ebook.pdf.pdf.pdf
Corona ebook.pdf.pdf.pdfCorona ebook.pdf.pdf.pdf
Corona ebook.pdf.pdf.pdf
 
SUMMARIZE EACH SECTION OF THE Identify.pdf
SUMMARIZE EACH SECTION OF THE Identify.pdfSUMMARIZE EACH SECTION OF THE Identify.pdf
SUMMARIZE EACH SECTION OF THE Identify.pdf
 
Monkeypox Disease.pptx
Monkeypox Disease.pptxMonkeypox Disease.pptx
Monkeypox Disease.pptx
 
Dns
DnsDns
Dns
 

Último

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.pptraviapr7
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 

Último (20)

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.ppt
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 

Opening Prayer for an Important Event

  • 1.
  • 2. OPENING PRAYER DEAR HEAVENLY FATHER, WE THANK YOU FOR GATHERING ALL OF US TODAY IN THIS IMPORTANT EVENT MAY YOU BESTOW YOUR GUIDANCE AND BLESSINGS ON THIS EVENT, SO THAT WE CAN ENJOY AND APPRECIATE ITS SIGNIFICANCE IN OUR LIVES BLESS EVERYONE PRESENT HERE TODAY, THAT EACH OF US MAY BE ABLE TO SHARE WHAT HE OR SHE HAVE, FOR YOUR GLORY AND HONOR GRANT GOOD HEALTH AND SAFETY TO OUR LOVED ONES LEFT AT HOME, AND PEACE AND GOOD WILL TO ALL MEN. MAY THE VARIOUS ACTIVITIES RELATED TO THIS EVENT BE A SUCCESS, THROUGH YOUR INTERVENTION WE ASK ALL OF THESE IN YOUR NAME, AMEN.
  • 3. HUMAN MONKEYPOX By: GERESA G. SALTA-SAMONTE,M.D. Occupational/ Family Medicine Infectious Diseases & Tropical Medicine
  • 4. Few Questions Before We Start  1. Are monkeys the natural reservoir of monkeypox virus?  2. How can we differentiate monkeypox from chickenpox?  3. What is the duration of quarantine if you have been exposed to someone with monkeypox?
  • 6.  1st identified in monkeys in 1958  1st human case reported in 1970  Endemic in areas of Africa  Typically, only see sporadic cases outside of Africa in people who have traveled to certain regions or have been in close contact with those travelers  From the 1970s up until 2003, sporadic cases were identified in central and western Africa  Before 1980, case-fatality rate was 17% and secondary transmission was the cause in 9% of cases  From 1981 to 1986, the case-fatality rate was 10% and secondary transmission was the cause in 28%  From 1996 to 1997, the largest outbreak of human monkeypox occurred, which had a case-fatality rate of 1.5% and secondary transmission was the cause in 78%  The 2003 outbreak, was the first documented cases in the western hemisphere with a case-fatality rate of 0% and secondary transmission was the cause in 0%  Cases of Monkeypox in 2022 from May 6th – 20th [2]:  UK: 20 (Confirmed)  Spain: 23 (Unconfirmed)  Portugal 5 (Confirmed) + 15 (Unconfirmed)  US 1 (Confirmed)
  • 7. What is Monkeypox?  Monkeypox is a disease caused by the monkeypox virus. It is a viral zoonotic disease, meaning that it can spread from animals to humans. It can also spread between people.  The disease is called monkeypox because it was first identified in colonies of monkeys kept for research in 1958. It was only later detected in humans in 1970.
  • 8. Mode of transmissions: Primary infection (animal to human) a) contact with infected animals b) contact with infected animal products  Secondary infection (human to human) a) contact with infected people b) mother to fetus
  • 9.
  • 10.
  • 11. Is Monkeypox a sexually transmitted disease?  Monkeypox can spread from one person to another through close physical contact, including sexual contact. It is currently not known whether monkeypox can be spread through sexual transmission routes (e.g., through semen or vaginal fluids), but direct skin-to-skin contact with lesions during sexual activities can spread the virus.  Monkeypox rashes are sometimes found on genitals and in the mouth, which is likely to contribute to transmission during sexual contact. Mouth-to-skin contact could thus cause transmission where skin or mouth lesions are present.
  • 13. Disease Progression:  Incubation period (5- 21 days)= the virus enters the body & replicates. No symptoms. Virus is present in the blood at the end of this stage  Febrile stage ( 1-4 days)= fever is present plus other symptoms like headache, chills, sore throat, malaise, fatigue, swollen lymph nodes (lymphadenopathy). Virus is present in the blood & small lesions in the mouth may appear towards the end.  Rash stage2 (4 weeks)  Recovery (days to weeks)
  • 14. Rash Stage  Rash begins as maculopapular lesions of 2 to 5mm in diameter  Typically, centrifugal pattern (from the torso outwards)  Skin lesions typically progress from macular, papular, to vesicular, to pustular, and crust phases over a 14 to 21-day period  In patients with smallpox vaccination the rash will be milder and only ≈50% will have lymphadenopathy
  • 16.
  • 17.
  • 18.  Rash stage - virus maybe in the blood in the early stage - virus is present in the skin lesions - antibodies are produced & detectable  Recovery stage - patient recovers - antibodies are present in the blood - scars may remain - no more symptoms
  • 19.
  • 20. Factors affecting the course of the disease: 1. Asymptomatic infection may occur 2. Risk factors for severe illness: a) children b) immunocompromised c) invasive route 3. Prior smallpox vaccination
  • 21. Complications:  Bacterial superinfection of skin  Skin scarring  Corneal scarring/vision loss  Pneumonia  Dehydration (secondary to painful oral lesions and insensible fluid loss)  Encephalitis  Death (Very rare)
  • 22. How can we protect ourselves against monkeypox?  by limiting contact with people who have suspected or confirmed monkeypox.  If you do need to have physical contact with someone who has monkeypox because you are a health worker or live together, encourage the infected person to self-isolate and cover any skin lesion if they can (e.g., by wearing clothing over the rash).  wear a medical mask, especially if they are coughing or have lesions in their mouth. You should wear one also.
  • 23.  Avoid skin-to-skin contact whenever possible and use disposable gloves if you have any direct contact with lesions.  Wear a mask when handling any clothes or bedding if the person cannot do it themselves.  Regularly clean your hands with soap and water or an alcohol-based hand rub  Wash the person’s clothes, towels and bedsheets and eating utensils with warm water and detergent.
  • 24. What to do when you think you have monkeypox?  Self-isolate  Avoid close contact  Clean hands regularly  Contact your physicians
  • 25. Treatment:  There is no proven treatment for monkeypox  For contacts of a case, recommend twice daily fever/symptom monitoring for 21 days + Isolation recommended  Currently, CDC recommending airborne and contact precautions (i.e. negative pressure room, N95, gloves, and eye shield)  Pre-exposure smallpox vaccination has been shown to confer 85% protection against monkeypox  Role of post-exposure smallpox vaccination is less clear  According to the CDC, vaccination within 4 days of exposure may prevent disease onset and vaccination within 14 days may reduce disease severity